Vitamin E supplementation and mammalian lifespan

Molecular Nutrition and Food Research

Volumn 54, Issue 5, 2010, Pages 719-725

  Banks, Ruth ^a   Speakman, John R ^a   Selman, Colin ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

tocopherol; Lifespan; Oxidative stress; P21; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; XENOBIOTIC AGENT;

ANIMAL; C57BL MOUSE; DIET SUPPLEMENTATION; FEMALE; GROWTH, DEVELOPMENT AND AGING; HEALTH STATUS; HUMAN; INTESTINE ABSORPTION; LIFE EXPECTANCY; LONGEVITY; MAMMAL; METABOLISM; MOUSE; PHYSIOLOGY; RAT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIETARY SUPPLEMENTS; FEMALE; HEALTH STATUS; HUMANS; INTESTINAL ABSORPTION; LIFE EXPECTANCY; LONGEVITY; MAMMALS; MICE; MICE, INBRED C57BL; RATS; SIGNAL TRANSDUCTION; VITAMIN E; XENOBIOTICS;

MAMMALIA; MUS; RODENTIA;

EID: 77952341522     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900382     Document Type: Review

References (90)

1. Evans, H. M., Bishop, K. S., On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922, 56, 650-651.
2. Azzi, A., Gysin, R., Kempna, P., Ricciarelli, R. et al., The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events. Mol. Aspects Med. 2003, 24, 325-336.
3. Meydani, M., Lipman, R. D., Han, S. N., Wu, D. et al., The effect of long-term dietary supplementation with antioxidants. Ann. NY Acad. Sci. 1998, 854, 352-360.
4. Traber, M. G., Vitamin E regulatory mechanisms. Annu. Rev. Nutr. 2007, 27, 347-362.
5. Mustacich, D. J., Bruno, R. S., Traber, M. G., Vitamin E. Vitam. Horm. 2007, 76, 1-21.
6. Azzi, A., Stocker, A., Vitamin E: non-antioxidant roles. Prog. Lipid Res. 2000, 39, 231-255.
7. Brigelius-Flohé, R., Vitamin E: the shrew waiting to be tamed. Free Radic. Biol. Med. 2009, 46, 543-554.
8. Traber, M. G., Atkinson, J., Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med. 2007, 43, 4-15.
9. Azzi, A., Molecular mechanism of alpha-tocopherol action. Free Radic. Biol. Med. 2007, 43, 16-21.
10. Hoppe, P. P., Krennrich, G., Bioavailability and potency of natural-source and all-rac α-tocopherol in the human: a dispute. Eur. J. Nutr. 2000, 39, 183-193.
11. Fuhrmann, H., Balthazary, S. T., Sallmann, H. P., Bioefficiency of different tocopherols in chicken as assessed by haemolysis test and microsomal pentane production. Br. J. Nutr. 1994, 71, 605-614.
12. Leonard, S. W., Terasawa, Y., Farese, R. V., Jr., Traber, M. G., Incorporation of deuterated RRR-or all-rac-alpha-tocopherol in plasma and tissues of alpha-tocopherol transfer protein - null mice. Am. J. Clin. Nutr. 2002, 75, 555-560.
13. Zimmer, S., Stocker, A., Sarbolouki, M. N., Spycher, S. E. et al., A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J. Biol. Chem. 2000,275,25672-25680.
14. Traber, M. G., Burton, G. W., Hamilton, R. L., Vitamin E trafficking. Ann. NY Acad. Sci. 2004, 1031, 1-12.
15. Arita, M., Nomura, K., Arai, H., Inoue, K., Alpha-tocopherol transfer protein stimulates the secretion of alpha-tocopherol from a cultured liver cell line through a brefeldin A-insensitive pathway. Proc. Natl. Acad. Sci. USA 1997, 94, 12437-12441.
16. Catignani, G. L., An alpha-tocopherol binding protein in rat liver cytoplasm. Biochem. Biophys. Res. Commun. 1975, 67, 66-72.
17. Traber, M. G., Frei, B., Beckman, J. S., Vitamin E revisited: do new data validate benefits for chronic disease prevention? Curr. Opin. Lipidol. 2008, 19, 30-38.
18. Sokol, R. J., Vitamin E and neurologic function in man. Free Radic. Biol. Med. 1989, 6, 189-207.
19. Aslam, A., Misbah, S. A., Talbot, K., Chapel, H., Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency. Clin. Immunol. 2004, 112, 24-29.
20. Devereux, G., Turner, S. W., Craig, L. C., McNeill, G. et al., Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am. J. Respir. Crit. Care Med. 2006, 174, 499-507.
21. Okura, Y., Tawara, S., Kikusui, T., Takenaka, A., Dietary vitamin E deficiency increases anxiety-related behavior in rats under stress of social isolation. Biofactors 2009, 35, 273-278.
22. Huang, H. S., Chen, J., Chen, C. F., Ma, M. C., Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int. 2006,70,699-710.
23. Nishida, Y., Ito, S., Ohtsuki, S., Yamamoto, N. et al., Depletion of vitamin E increases Abeta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease. J. Biol. Chem. 2009, 284, 33400-33408.
24. Duthie, S. J., Gardner, P. T., Morrice, P. C., Wood, S. G. et al., DNA stability and lipid peroxidation in vitamin E-deficient rats in vivo and colon cells in vitro - modulation by the dietary anthocyanin, cyanidin-3-glycoside. Eur. J. Nutr. 2005, 44, 195-203.
25. Tanito, M., Yoshida, Y., Kaidzu, S., Chen, Z. H. et al., Acceleration of age-related changes in the retina in alpha-tocopherol transfer protein null mice fed a Vitamin E-deficient diet. Invest. Ophthalmol. Vis. Sci. 2007, 48, 396-404.
26. Cuddihy, S. L., Ali, S. S., Musiek, E. S., Lucero, J. et al., Prolonged alpha-tocopherol deficiency decreases oxidative stress and unmasks alpha-tocopherol-dependent regulation of mitochondrial function in the brain. J. Biol. Chem. 2008, 283,6915-6924.
27. Dietrich, M., Traber, M. G., Jacques, P. F., Cross, C. E. et al., Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer? A review. J. Am. Coll. Nutr. 2006, 25, 292-299.
28. Clarke, M. W., Burnett, J. R., Croft, K. D., Vitamin E in human health and disease. Crit. Rev. Clin. Lab. Sci. 2008, 45, 417-450.
29. Ascherio, A., Weisskopf, M. G., O'Reilly E. J., Jacobs, E. J. et al., Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann. Neurol. 2005, 57, 104-110.
30. Pratico, D., Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann. NY Acad. Sci. 2008, 1147, 70-78.
31. Pratico, D., Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol. Sci. 2008, 29, 609-615.
32. Marko, M. G., Pang, H. J., Ren, Z., Azzi, A. et al., Vitamin E reverses impaired linker for activation of T cells activation in T cells from aged C57BL/6 mice. J. Nutr. 2009, 139, 1192-1197.
33. Zingg, J. M., Azzi, A., Meydani, M., Genetic polymorphisms as determinants for disease-preventive effects of vitamin E. Nutr. Rev. 2008, 66, 406-414.
34. Ristow, M., Zarse, K., Oberbach, A., Kloting, N. et al., Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA 2009, 106, 8665-8670.
35. Milman, U., Blum, S., Shapira, C., Aronson, D. et al., Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 341-347.
36. Belisle, S. E., Leka, L. S., Delgado-Lista, J., Jacques, P. F. et al., Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine production in the elderly. J. Nutr. 2009, 139, 1855-1860.
37. Miller, E. R., III, Pastor-Barriuso, R., Dalal, D., Riemersma, R. A. et al., Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 2005, 142, 37-46.
38. Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., Gluud, C., Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. J. Am. Med. Assoc. 2007,297,842-857.
39. Selman, C., McLaren, J. S., Mayer, C., Duncan, J. S. et al., Lifelong alpha-tocopherol supplementation increases the median life span of C57BL/6 mice in the cold but has only minor effects on oxidative damage. Rejuvenation Res. 2008, 11,83-96.
40. Porta, E. A., Joun, N. S., Nitta, R. T., Effects of the type of dietary fat at two levels of vitamin E in Wistar male rats during development and aging. I. Life span, serum biochemical parameters and pathological changes. Mech. Ageing Dev. 1980, 13, 1-39.
41. Blackett, A. D., Hall, D. A., The effects of vitamin E on mouse fitness and survival. Gerontology 1981, 27, 133-139.
42. Navarro, A., Gomez, C., Sanchez-Pino, M. J., Gonzalez, H. et al., Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R1392-R1399.
43. Hsieh, C. C., Lin, B. F., Opposite effects of low and high dose supplementation of vitamin E on survival of MRL/lpr mice. Nutrition 2005, 21, 940-948.
44. Blackett, A. D., Hall, D. A., Vitamin E - its significance in mouse ageing. Age Ageing 1981, 10, 191-195.
45. Veurink, G., Liu, D., Taddei, K., Perry, G. et al., Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. Free Radic. Biol. Med. 2003, 34,1070-1077.
46. Bezlepkin, V. G., Sirota, N. P., Gaziev, A. I., The prolongation of survival in mice by dietary antioxidants depends on their age by the start of feeding this diet. Mech. Ageing Dev. 1996,92,227-234.
47. Morley, A. A., Trainor, K. J., Lack of an effect of vitamin E on lifespan of mice. Biogerontology 2001, 2, 109-112.
48. Sumien, N., Forster, M. J., Sohal, R. S., Supplementation with vitamin E fails to attenuate oxidative damage in aged mice. Exp. Gerontol. 2003, 38, 699-704.
49. Lipman, R. D., Bronson, R. T., Wu, D., Smith, D. E. et al., Disease incidence and longevity are unaltered by dietary antioxidant supplementation initiated during middle age in C57BL/6 mice. Mech. Ageing Dev. 1998, 103, 269-284.
50. Holloszy, J. O., Longevity of exercising male rats: effect of an antioxidant supplemented diet. Mech. Ageing Dev. 1998, 100,211-219.
51. Martin, A., Janigian, D., Shukitt-Hale, B., Prior, R. L., Joseph, J. A., Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations. Brain Res. 1999, 845,50-59.
52. Chen, H. W., Cook, L. R., Hendrich, S., Gender and dietary fat affect alpha-tocopherol status in F344/N rats. Lipids 1992,27,844-846.
53. Gohil, K., Oommen, S., Quach, H. T., Vasu, V. T. et al., Mice lacking alpha-tocopherol transfer protein gene have severe alpha-tocopherol deficiency in multiple regions of the central nervous system. Brain Res. 2008, 1201, 167-176.
54. Tiidus, P. M., Bombardier, E., Hidiroglou, N., Madere, R., Gender and exercise influence on tissue antioxidant vitamin status in rats. J. Nutr. Sci. Vitaminol. (Tokyo) 1999, 45, 701-710.
55. Selman, C., McLaren, J. S., Collins, A. R., Duthie, G. G., Speakman, J. R., The impact of experimentally elevated energy expenditure on oxidative stress and lifespan in the short-tailed field vole Microtus agrestis. Proc. Biol. Sci. 2008,275,1907-1916.
56. Selman, C., Korhonen, T. K., Bunger, L., Hill, W. G., Speak-man, J. R., Thermoregulatory responses of two mouse Mus musculus strains selectively bred for high and low food intake. J. Comp. Physiol. [B] 2001, 171, 661-668.
57. Azzi, A., Oxidative stress: a dead end or a laboratory hypothesis? Biochem. Biophys. Res. Commun. 2007, 362, 230-232.
58. Selman, C., McLaren, J. S., Meyer, C., Duncan, J. S. et al., Life-long vitamin C supplementation in combination with cold exposure does not affect oxidative damage or lifespan in mice, but decreases expression of antioxidant protection genes. Mech. Ageing Dev. 2006, 127, 897-904.
59. Vasu, V. T., Hobson, B., Gohil, K., Cross, C. E., Genome-wide screening of alpha-tocopherol sensitive genes in heart tissue from alpha-tocopherol transfer protein null mice (ATTP(-/-)). FEBS Lett. 2007, 581, 1572-1578.
60. Vasu, V. T., Oommen, S., Lim, Y., Valacchi, G. et al., Modulation of ozone-sensitive genes in alpha-tocopherol transfer protein null mice. Inhal. Toxicol. 2009, 22, 1-16.
61. Han, S. N., Adolfsson, O., Lee, C. K., Prolla, T. A. et al., Age and vitamin E-induced changes in gene expression profiles of T cells. J. Immunol. 2006, 177, 6052-6061.
62. Mustacich, D. J., Gohil, K., Bruno, R. S., Yan, M. et al., Alpha-tocopherol modulates genes involved in hepatic xenobiotic pathways in mice. J. Nutr. Biochem. 2009, 20, 469-476.
63. Birringer, M., Drogan, D., Brigelius-Flohé, R., Tocopherols are metabolized in HepG2 cells by side chain omega-oxidation and consecutive beta-oxidation. Free Radic. Biol. Med. 2001, 31, 226-232.
64. Traber, M. G., Elsner, A., Brigelius-Flohé, R., Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated alpha-tocopheryl acetates. FEBS Lett. 1998, 437, 145-148.
65. Abe, C., Uchida, T., Ohta, M., Ichikawa, T. et al., Cytochrome P450-dependent metabolism of vitamin E isoforms is a critical determinant of their tissue concentrations in rats. Lipids 2007, 42, 637-645.
66. Brigelius-Flohé, R., Traber, M. G., Vitamin E: function and metabolism. FASEB J. 1999, 13, 1145-1155.
67. 0-carboxyethyl)-6-hydroxychroman, gamma-tocopherol metabolite, in rats. Lipids 2001, 36, 467-472.
68. Ju, Z., Choudhury, A. R., Rudolph, K. L., A dual role of p21 in stem cell aging. Ann. NY Acad. Sci. 2007, 1100, 333-344.
69. Gartel, A. L., p21(WAF1/CIP1) and cancer: a shifting paradigm? Biofactors 2009, 35, 161-164.
70. Morante, M., Sandoval, J., Gomez-Cabrera, M. C., Rodriguez, J. L. et al., Vitamin E deficiency induces liver nuclear factor-kappaB DNA-binding activity and changes in related genes. Free Radic. Res. 2005, 39, 1127-1138.
71. Lee, H. J., Ju, J., Paul, S., So, J. Y. et al., Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma. Clin. Cancer Res. 2009, 15,4242-4249.
72. Chinery, R., Brockman, J. A., Peeler, M. O., Shyr, Y. et al., Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta. Nat. Med. 1997, 3, 1233-1241.
73. Chen, W., Sun, Z., Wang, X. J., Jiang, T. et al., Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol. Cell. 2009, 34, 663-673.
74. Raderschall, E., Bazarov, A., Cao, J., Lurz, R. et al., Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. J. Cell. Sci. 2002, 115, 153-164.
75. Han, E. S., Muller, F. L., Perez, V. I., Qi, W. et al., The in vivo gene expression signature of oxidative stress. Physiol. Genomics 2008, 34, 112-126.
76. Sakai, M., Okabe, M., Tachibana, H., Yamada, K., Apoptosis induction by gamma-tocotrienol in human hepatoma Hep3B cells. J. Nutr. Biochem. 2006, 17, 672-676.
77. Ahn, K. S., Sethi, G., Krishnan, K., Aggarwal, B. B., Gammatocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J. Biol. Chem. 2007, 282,809-820.
78. Yap, W. N., Chang, P. N., Han, H. Y., Lee, D. T. et al., Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. Br. J. Cancer 2008, 99, 1832-1841.
79. Chang, P. N., Yap, W. N., Lee, D. T., Ling, M. T. et al., Evidence of gamma-tocotrienol as an apoptosis-inducing, invasion-suppressing, and chemotherapy drug-sensitizing agent in human melanoma cells. Nutr. Cancer 2009, 61, 357-366.
80. Constantinou, C., Papas, A., Constantinou, A. I., Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs. Int. J. Cancer 2008, 123, 739-752.
81. Elangovan, S., Hsieh, T. C., Wu, J. M., Growth inhibition of human MDA-mB-231 breast cancer cells by delta-toco-trienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res. 2008, 28, 2641-2647.
82. Hussein, D., Mo, H., d-Dlta-tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas 2009, 38, e124-e136.
83. Nesaretnam, K., Multitargeted therapy of cancer by tocotrienols. Cancer Lett. 2008, 269, 388-395.
84. Weng-Yew, W., Selvaduray, K. R., Ming, C. H., Nesaretnam, K., Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis. Nutr. Cancer 2009, 61, 367-373.
85. Shibata, A., Nakagawa, K., Sookwong, P., Tsuduki, T. et al., Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible factor-1alpha. J. Nutr. 2008, 138, 2136-2142.
86. Shibata, A., Nakagawa, K., Sookwong, P., Tsuzuki, T. et al., Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. Biochem. Pharmacol. 2008, 76, 330-339.
87. Kashiwagi, K., Harada, K., Yano, Y., Kumadaki, I. et al., A redox-silent analogue of tocotrienol inhibits hypoxic adaptation of lung cancer cells. Biochem. Biophys. Res. Commun. 2008, 365, 875-881.
88. Kashiwagi, K., Virgona, N., Harada, K., Kido, W. et al., A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells. Life Sci. 2009,84,650-656.
89. Selman, C., Kerrison, N. D., Cooray, A., Piper, M. D. et al., Coordinated multitissue transcriptional and plasma metabonomic profiles following acute caloric restriction in mice. Physiol. Genomics 2006, 27, 187-200.
90. Ohtani, N., Imamura, Y., Yamakoshi, K., Hirota, F. et al., Visualizing the dynamics of p21(Waf1/Cip1) cyclin-dependent kinase inhibitor expression in living animals. Proc. Natl. Acad. Sci. USA 2007, 104, 15034-15039.